BRIEF-Applied Therapeutics Provides Update Following Meeting With FDA

Reuters

Sep 29

BRIEF-<a href="https://laohu8.com/S/AMAT">Applied</a> <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Provides Update Following Meeting With FDA

Sept 29 (Reuters) - Applied Therapeutics Inc APLT.O:

APPLIED THERAPEUTICS PROVIDES UPDATE FOLLOWING MEETING WITH FDA
APPLIED THERAPEUTICS INC - COMPLETES FDA MEETING ON GOVORESTAT NDA
APPLIED THERAPEUTICS INC - DISCUSSIONS ON GOVORESTAT NDA FOR CMT-SORD IN Q3 2025
APPLIED THERAPEUTICS INC - AWAITING FDA MEETING MINUTES FOR NEXT STEPS

Source text: ID:nGNX1kM1CR

Further company coverage: APLT.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2571387417"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2571387417\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2571387417?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-09-29 19:18","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2571387417","market":"nz","top_or_hot":-1,"title":"BRIEF-Applied Therapeutics Provides Update Following Meeting With FDA","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-<a href=\"https://laohu8.com/S/AMAT\">Applied</a> <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Provides Update Following Meeting With FDA</title></head><body><p><span>Sept 29 (Reuters)</span><span> - </span>Applied Therapeutics Inc <span>APLT.O</span>:</p><ul><li><p>APPLIED THERAPEUTICS PROVIDES UPDATE FOLLOWING MEETING WITH FDA</p></li><li><p>APPLIED THERAPEUTICS INC - COMPLETES FDA MEETING ON GOVORESTAT NDA</p></li><li><p>APPLIED THERAPEUTICS INC - DISCUSSIONS ON GOVORESTAT NDA FOR CMT-SORD IN Q3 2025</p></li><li><p>APPLIED THERAPEUTICS INC - AWAITING FDA MEETING MINUTES FOR NEXT STEPS</p></li></ul><p>Source text: <span>ID:nGNX1kM1CR</span></p><p>Further company coverage: <span>APLT.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Applied Therapeutics Provides Update Following Meeting With FDA</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Applied Therapeutics Provides Update Following Meeting With FDA\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-09-29 19:18</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-<a href=\"https://laohu8.com/S/AMAT\">Applied</a> <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Provides Update Following Meeting With FDA</title></head><body><p><span>Sept 29 (Reuters)</span><span> - </span>Applied Therapeutics Inc <span>APLT.O</span>:</p><ul><li><p>APPLIED THERAPEUTICS PROVIDES UPDATE FOLLOWING MEETING WITH FDA</p></li><li><p>APPLIED THERAPEUTICS INC - COMPLETES FDA MEETING ON GOVORESTAT NDA</p></li><li><p>APPLIED THERAPEUTICS INC - DISCUSSIONS ON GOVORESTAT NDA FOR CMT-SORD IN Q3 2025</p></li><li><p>APPLIED THERAPEUTICS INC - AWAITING FDA MEETING MINUTES FOR NEXT STEPS</p></li></ul><p>Source text: <span>ID:nGNX1kM1CR</span></p><p>Further company coverage: <span>APLT.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0320765992.SGD","symbol_name":"FTIF - Franklin Biotechnology Discovery A Acc SGD","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250929:nTUA2LPNW4:1","article_id":"2571387417","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2571387417","pubTimestamp":1759144720,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Applied Therapeutics Provides Update Following Meeting With FDASept 29 (Reuters) - Applied Therapeutics Inc APLT.O:APPLIED THERAPEUTICS PROVIDES UPDATE FOLLOWING MEETING WITH FDAAPPLIED THERAPEU","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU0320765992.SGD":"FTIF - Franklin Biotechnology Discovery A Acc SGD","BK4139":"生物科技","LU0109394709.USD":"富兰克林生物科技新领域基金A (acc)","LU0889565916.HKD":"FRANKLIN BIOTECHNOLOGY DISCOVERY \"A\" (HKD) ACC","APLT":"Applied Therapeutics Inc."},"translate_title":"简介-Applied Therapeutics在与FDA会面后提供最新信息","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"APLT":0.9},"content_text":"BRIEF-Applied Therapeutics Provides Update Following Meeting With FDASept 29 (Reuters) - Applied Therapeutics Inc APLT.O:APPLIED THERAPEUTICS PROVIDES UPDATE FOLLOWING MEETING WITH FDAAPPLIED THERAPEUTICS INC - COMPLETES FDA MEETING ON GOVORESTAT NDAAPPLIED THERAPEUTICS INC - DISCUSSIONS ON GOVORESTAT NDA FOR CMT-SORD IN Q3 2025APPLIED THERAPEUTICS INC - AWAITING FDA MEETING MINUTES FOR NEXT STEPSSource text: ID:nGNX1kM1CRFurther company coverage: APLT.O ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}